Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe
ECDC comment on the study 'Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018' by Eyre et al. in the Eurosurveillance edition of 7 March 2019.
Gonorrhoea: drug resistance compromises recommended treatment in Europe
Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme.
Gonococcal antimicrobial susceptibility surveillance in Europe, 2017
The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2017 gonococcal antimicrobial susceptibility sentinel surveillance.
Communicable disease threats report, 17-23 February 2019, week 8
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period from 17-23 February 2019 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), chikungunya virus disease and dengue, Ebola virus disease, influenza, Neisseria gonorrhoeae, Salmonella Poona and influenza A(H9N2).
Health risks during the Carnival season in Brazil
The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
Communicable disease threats report, 6-12 January 2019, week 2
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 12-18 January 2019 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), measles, rubella, Ebola virus disease, influenza and Neisseria gonorrhoeae.
Call for scientific collaboration to support genomic-based surveillance of Neisseria gonorrhoeae-antimicrobial resistance at EU-level
ECDC is looking to establish a scientific collaboration with an organisation which can perform whole genome sequencing (WGS) of Neisseria gonorrhoeae, carry out related data analyses, share results of the analyses with ECDC and the participants of the European Gonococcal Antimicrobial Surveillance Programme as well as visualise the results.
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016
Day, M.J., Spiteri, G., Jacobsson, S., Woodford, N., Amato-Gauci, A.J., Cole, M.J., Unemo, M., Indra, A., Huhlescu, S., Vanden Berghe, W., Crucitti, T., Hunjak, B., Nemeth Blažić, T., Kubele, J., Zákoucká, H., Žemličková, H., Berthelsen, L., Cowan, S., Hoffmann, S., Epstein, J., Viktorova, J., Ndeikoundam, N., Goubard, A., Bercot, B., Kohl, P., Buder, S., Bremer, V., Jansen, K., Tzelepi, E., Konte, V., Balla, E., Dudás, M., Sigmundsdóttir, G., Hauksdóttir, G.S., Igoe, D., Crowley, B., Suligoi, B., Stefanelli, P., Pakarna, G., Mavcutko, V., Reichert, P., Hoffmann, P., Barbara, C., Vella, F., Melillo, J.M., Van Dam, A., Van Benthem, B., Linde, I., Kløvstad, H., Steinbakk, M., Majewski, S., Młynarczyk-Bonikowska, B., Azevedo, J., Borrego, M.-J., Pavlik, P., Truska, P., Klavs, I., Jeverica, S., Vazquez, J., Diaz, A., Abad, R., Velicko, I., Hughes, G., Templeton, K., Irvine, N.
Lymphogranuloma venereum (LGV) in men who have sex with men (MSM): A re-emerging problem, Malta, 2018
Donachie, A., Spiteri, G., Barbara, C., Melillo, T., Hadad, R., Farrugia, A.G., Unemo, M., Padovese, V.